CID 139394142

Vebicorvir

Structural Information

Molecular Formula
C19H12F3N3O4S2
SMILES
C1=CC=C2C(=C1)C(=O)NC3=C(S2(=O)=O)C=CC(=C3)C(=O)NCC4=CN=C(S4)C(F)(F)F
InChI
InChI=1S/C19H12F3N3O4S2/c20-19(21,22)18-24-9-11(30-18)8-23-16(26)10-5-6-15-13(7-10)25-17(27)12-3-1-2-4-14(12)31(15,28)29/h1-7,9H,8H2,(H,23,26)(H,25,27)
InChIKey
LBJVBJYMZKEREY-UHFFFAOYSA-N
Compound name
6,11,11-trioxo-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-5H-benzo[b][1,4]benzothiazepine-3-carboxamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

3
References

585
Patents

467.02213 Da
Monoisotopic Mass

2.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 468.02941 191.8
[M+Na]+ 490.01135 197.7
[M+NH4]+ 485.05595 195.7
[M+K]+ 505.98529 191.9
[M-H]- 466.01485 188.9
[M+Na-2H]- 487.99680 195.0
[M]+ 467.02158 192.3
[M]- 467.02268 192.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe